dihydroergocryptine has been researched along with Parkinson Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, MR | 1 |
Albanese, A; Colosimo, C | 1 |
Gasser, T; Pöpperl, G; Ruzicka, E; Schwarz, J; Storch, A; Tatsch, K | 1 |
Magnani, P; Mailland, E; Ottillinger, B | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
3 review(s) available for dihydroergocryptine and Parkinson Disease
Article | Year |
---|---|
DA agonists -- ergot derivatives: dihydroergocryptine (DHEC): management of Parkinson's disease.
Topics: Dihydroergocryptine; Dopamine Agonists; Ergot Alkaloids; Humans; Parkinson Disease; Randomized Controlled Trials as Topic | 2002 |
Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists.
Topics: Clinical Trials as Topic; Dihydroergocryptine; Dopamine Agonists; Humans; Parkinson Disease; Treatment Outcome | 2003 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
2 trial(s) available for dihydroergocryptine and Parkinson Disease
Article | Year |
---|---|
Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
Topics: Adolescent; Aged; Caudate Nucleus; Dihydroergocryptine; Dopamine Plasma Membrane Transport Proteins; Double-Blind Method; Female; Follow-Up Studies; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes | 2004 |
Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Dihydroergocryptine; Female; Gait Disorders, Neurologic; Humans; Levodopa; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Speech Disorders; Tremor | 2004 |
1 other study(ies) available for dihydroergocryptine and Parkinson Disease
Article | Year |
---|---|
The history of ergot of rye (Claviceps purpurea) III: 1940-80.
Topics: Bromocriptine; Claviceps; Dihydroergocryptine; Ergot Alkaloids; History, 20th Century; Humans; Lysergic Acid Diethylamide; Parkinson Disease; Prolactinoma; Receptors, Dopamine; Schizophrenia; Scotland; Secale | 2010 |